On Wednesday, several HIV experts spoke at a Capitol Hill briefing “supporting the U.S. President’s Emergency Plan for AIDS Relief (PEPFAR) program’s reliance on scientific evidence to drive its work to end AIDS,” the Center for Global Health Policy’s “Science Speaks” blog reports. The speakers, including Diane Havlir of the University of California, San Francisco, RJ Simonds of the Elizabeth Glaser Pediatric AIDS Foundation, Renee Ridzon of the Bill & Melinda Gates Foundation, and Chris Beyrer of the Johns Hopkins School of Public Health, talked about using antiretroviral treatment as a prevention method, the prevention of mother-to-child HIV transmission, voluntary medical male circumcision, and preventing HIV among marginalized populations at high risk of infection (Mazzotta, 2/3).
The Center for Global Health Policy’s “Science Speaks” blog describes a Capitol Hill briefing that was held Wednesday “to discuss the various evidence-based approaches to prevent HIV infection that the U.S. President’s Emergency Plan for AIDS Relief (PEPFAR) program is implementing on the ground in the countries hardest hit by the AIDS pandemic.” According to the blog, “The briefing was the first in a series that will be hosted by the Office of the Global AIDS Coordinator in the months leading up to the International AIDS Conference in Washington, D.C., in July. This briefing was co-hosted by the Center, the Foundation for AIDS Research (amfAR), and PEPFAR (Mazzotta, 2/1).
“This week marks the 10th anniversary of the creation of the Global Fund to Fight AIDS, Tuberculosis and Malaria — the world’s most powerful tool for improving health — at the World Economic Forum (WEF) in Davos, Switzerland,” Natasha Bilimoria, president of Friends of the Global Fight Against AIDS, Tuberculosis and Malaria, writes in this post in the AlertNet “Insight” blog. During an announcement at the WEF on Wednesday that the Bill & Melinda Gates Foundation will donate an additional $750 million to the Global Fund, Bill Gates said, “By supporting the Global Fund, we can help to change the fortunes of the poorest countries in the world,” Bilimoria says, writing, “He’s right. … In total, the Global Fund is responsible for saving the lives of roughly 4,400 people every day.”
“Thirty years after AIDS made its deadly debut, a future without the disease is finally within reach,” a Boston Globe editorial states, adding, “But just as science is on the verge of winning the battle, financial resources and political will are flagging.” The editorial details reductions in HIV spending, a Congressional stipulation that U.S. funds cannot be spent on needle-exchange programs, and new science showing how HIV treatment can help people living with the disease live longer and reduce the risk of them spreading the virus.
In this video clip from NBC’s Today show, contributing correspondent Jenna Bush Hager reports on a recent family trip to Africa to visit PEPFAR-funded programs and to announce a new initiative by the George W. Bush Institute to fight cervical cancer. In the video, the Bushes travel to Tanzania, where they visit a PEPFAR-funded program called Jipende!, which trains hairstylists as health educators in 70 salons throughout the country, and to Zambia, where they visit the Ocean Road Cancer Institute and discuss a new initiative for cervical cancer testing, treatment and vaccination (12/22).
In this post on the Center for Global Development’s (CGD) “Global Health Policy” blog, Denizhan Duran and Amanda Glassman of CGD review the proposed FY12 federal global health appropriation approved recently by Congress. They state that “this year’s budget is a missed opportunity in a period defined by budget pressures: global…
The Center for Strategic & International Studies’ “Smart Global Health” blog highlights a report called “Terra Nova: How to Achieve a Successful PEPFAR Transition in South Africa,” writing, “The United States and South Africa are negotiating a complex, multi-year handoff that will shift financial and managerial responsibilities for HIV/AIDS to…
“Spending to improve health in developing countries has continued to grow during the three-year economic downturn, although at only half the blistering pace it did a decade ago,” according to a report (.pdf) by researchers at the University of Washington’s Institute for Health Metrics and Evaluation (IHME), the Washington Post reports (Brown, 12/14). “The report details the trends in development assistance for health between 1990 and 2009 from aid agencies and governments in 23 developed countries, multilateral institutions such as the [WHO], and hundreds of non-profit groups and charities with preliminary estimates for 2010 and 2011,” an IHME press release states (12/14). “Overall, spending on malaria and child health problems has grown more rapidly in the past few years than spending on AIDS and tuberculosis,” according to the report, the Washington Post notes (12/14).
In this Africa.com opinion piece, Ana Ruth Luis, medical director of the Southern Africa Strategic Business Unit at Chevron Africa and Latin America Ex in Angola, discusses what she calls “the important role Chevron has in driving down the incidence of HIV/AIDS in Africa.” She writes, “Chevron was able to drop new infections to zero among our employees and their babies by educating our employees, establishing a culture of voluntary, confidential testing and treatment, addressing stigma and discrimination in the workplace, and providing comprehensive medical care for expectant mothers.”
“We welcome the Obama administration’s announcement of a farsighted effort to treat millions more [people living with HIV] abroad, especially in sub-Saharan Africa,” a New York Times editorial writes. “The administration expects that the expanded treatments can be paid for with existing resources, by pushing for greater efficiencies and more financing from recipient nations. But if that effort stalls, the administration should re-evaluate quickly whether to ask Congress for money,” the editorial states.